Alyeska Investment Group’s Astria Therapeutics ATXS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Hold |
0
| – | – | – | 446 |
|
|
2023
Q4 | – | Hold |
0
| – | – | – | 440 |
|
|
2022
Q4 | – | Sell |
-274,719
| Closed | -$2.48M | – | 418 |
|
|
2022
Q3 | $2.48M | Hold |
274,719
| – | – | 0.03% | 303 |
|
|
2022
Q2 | $824K | Hold |
274,719
| – | – | 0.01% | 506 |
|
|
2022
Q1 | $1.84M | Hold |
274,719
| – | – | 0.02% | 442 |
|
|
2021
Q4 | $1.48M | Buy |
274,719
+50,000
| +22% | +$270K | 0.02% | 476 |
|
|
2021
Q3 | $1.99M | Buy |
224,719
+16,666
| +8% | +$147K | 0.02% | 499 |
|
|
2021
Q2 | $2.63M | Buy |
208,053
+86,169
| +71% | +$1.09M | 0.03% | 464 |
|
|
2021
Q1 | $2.11M | Buy |
+121,884
| New | +$2.11M | 0.03% | 451 |
|
|
2020
Q4 | – | Hold |
0
| – | – | – | 504 |
|
|
2020
Q3 | – | Hold |
0
| – | – | – | 459 |
|
|
2020
Q2 | – | Sell |
-1,007
| Closed | -$25K | – | 449 |
|
|
2020
Q1 | $25K | Sell |
1,007
-19,906
| -95% | -$494K | ﹤0.01% | 334 |
|
|
2019
Q4 | $742K | Buy |
+20,913
| New | +$742K | 0.01% | 309 |
|
|
2019
Q3 | – | Hold |
0
| – | – | – | 366 |
|
|
2019
Q2 | – | Hold |
0
| – | – | – | 392 |
|
|
2019
Q1 | – | Hold |
0
| – | – | – | 327 |
|
|
2018
Q4 | – | Hold |
0
| – | – | – | 319 |
|
|
2018
Q3 | – | Sell |
-18,692
| Closed | -$1.08M | – | 367 |
|
|
2018
Q2 | $1.08M | Buy |
18,692
+16,732
| +854% | +$963K | 0.01% | 363 |
|
|
2018
Q1 | $213K | Sell |
1,960
-1,685
| -46% | -$183K | ﹤0.01% | 397 |
|
|
2017
Q4 | $326K | Hold |
3,645
| – | – | ﹤0.01% | 379 |
|
|
2017
Q3 | $464K | Buy |
3,645
+65
| +2% | +$8.27K | ﹤0.01% | 413 |
|
|
2017
Q2 | $303K | Sell |
3,580
-108
| -3% | -$9.14K | ﹤0.01% | 415 |
|
|
2017
Q1 | $354K | Sell |
3,688
-43
| -1% | -$4.13K | ﹤0.01% | 441 |
|
|
2016
Q4 | $808K | Buy |
3,731
+444
| +14% | +$96.2K | 0.01% | 416 |
|
|
2016
Q3 | $1.22M | Buy |
+3,287
| New | +$1.22M | 0.01% | 395 |
|
|
2015
Q4 | – | Sell |
-670
| Closed | -$325K | – | 367 |
|
|
2015
Q3 | $325K | Sell |
670
-163
| -20% | -$79.1K | ﹤0.01% | 428 |
|
|
2015
Q2 | $611K | Buy |
+833
| New | +$611K | 0.01% | 420 |
|